MAPT and Alzheimer disease: Finally, the APOE4 allele, particularly in its homozygous form, is a well-established genetic risk factor for Alzheimer's disease (AD), influencing Aβ plaque formation, tau aggregation, and synaptic loss (Sun et al., 2023).